Order Information
Contact us
Insert title here
Featured Products
HY-10005  |  Flavopiridol
HY-10087  |  Navitoclax
HY-10128  |  ZM-447439
HY-10161  |  Tozasertib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10249  |  GSK-690693
HY-10358  |  MK 2206 (dihydrochloride)
HY-10997  |  PCI-32765
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-30237  |  Roscovitine
HY-50662  |  A-769662
HY-50767  |  Palbociclib
HY-50907  |  ABT-737
HY-50940  |  AT7519
HY-70044  |  GSK-1070916
HY-70061  |  Aurora A inhibitor I


 (Synonyms  AZD7762;AZD 7762)
860352-01-8  Technical Data: Price and Availability of  Cas No:860352-01-8

Cas : 860352-01-8 M.Wt: 362.42
Cas : 860352-01-8 Formula: C17H19FN4O2S
Cas : 860352-01-8 Purity: >98 %
Cas : 860352-01-8 Storage: at 20℃ 2 years
Cas : 860352-01-8 Solubility: 10 mM in DMSO
Cas : 860352-01-8 Name: AZD-7762
5mg/$72 In-stock
10mg/$110 In-stock
50mg/$358 In-stock
100mg/$468 In-stock
1g Get quote
5g Get quote
>10g Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please
inquire via sales@chemexpress.cn
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Online Inquiry
860352-01-8  Data Sheet:
Introduction of 860352-01-8 :
AZD-7762 is a potent ATP-competitive checkpoint kinase (Chk) inhibitor in with IC50 of 5 nM for Chk1. IC50 & Target: IC50: 5 nM (ChK1)[1] In Vitro: AZD-7762 (AZD7762) is an equally potent inhibitor of Chk1 and Chk2 in vitro. AZD-7762 potently inhibits Chk1 and Chk2, abrogates DNA damage-induced S and G2 checkpoints, enhances the efficacy of gemcitabine and topotecan, and modulates downstream checkpoint pathway proteins. AZD-7762 potently inhibits Chk1 phosphorylation of a cdc25C peptide with an IC50 of 5 nM as measured by a scintillation proximity assay. The Ki for AZD-7762 is determined to be 3.6 nM. Kinetic characterization suggests that AZD-7762 binds in the ATP-binding site of Chk1 and is thought to compete directly for ATP binding in a reversible manner. AZD-7762 is shown to abrogate the G2 arrest induced by Camptothecin with an average EC50 of 10 nM (n=12) and maximal abrogation in the range of 100 nM[1]. In Vivo: In the rat H460-DNp53 xenograft study, AZD-7762 (AZD7762) potentiates the antitumor activity of Gemcitabine in a dose-dependent manner by a decrease in %T/C with increasing dose (48% and 32%, 10 and 20 mg/kg AZD-7762, respectively). In the mouse xenograft study in combination with Irinotecan, SW620 established tumors are treated with vehicle, Irinotecan alone, AZD-7762 alone, or AZD-7762 in combination with Irinotecan. AZD-7762 dosed alone shows insignificant antitumor activity, whereas Irinotecan alone displays striking and significant activity (%T/C with increasing dose is 9 and 1, respectively ). In combination with AZD-7762, %T/C increases significantly to -66% and -67%, respectively[1].
References on 860352-01-8 :

Keywords: buy AZD-7762 | AZD-7762 Supplier | purchase AZD-7762 | AZD-7762 cost | AZD-7762 manufacturer | order AZD-7762 | AZD-7762 distributor | AZD-7762 structure
buy 860352-01-8 | 860352-01-8 Supplier | purchase 860352-01-8 | 860352-01-8 cost | 860352-01-8 manufacturer | order 860352-01-8 | 860352-01-8 distributor | 860352-01-8 structure
Insert title here
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn